Erba Diagnostics (ERB) is a fully integrated in vitro diagnostics company that has been in the midst of a turnaround for more than three years. The company was once a subsidiary of Phillip Frost's Ivax Corporation (previously named Ivax Diagnostics), and spun off into its own entity after Suresh Varizani bought the company in 2010 for approximately $15 million. Suresh Varizani is a Mumbai based entrepreneur who founded Transasia in 1979 with an initial bankroll of $5, and is currently the CEO of Erba Diagnostics Manheim. Through Erba Manheim, Varizani owns 82.4% of Erba Diagnostics. Erba Manheim is the parent company of Erba Diagnostics.
Erba Diagnostics, through the acquisition and consolidation of several companies, is composed of...
Only subscribers can access this article, which is part of the PRO research library covering 3,573 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: